Osler, Hoskin & Harcourt LLP Company Profile

07:11 EST 11th December 2018 | BioPortfolio

In the fall of 1862, five years before Confederation, Britton Bath Osler began to practise law in the village of Dundas, Upper Canada (now the Province of Ontario), about 40 miles west of Toronto. He was 23, entrepreneurial, and proved to be as good at business as he was at law.
Less than four years later, he opened a second office in the larger centre of Hamilton. The passing of another 10 years saw B.B. Osler start what became one of North America’s first commuter railways (between Hamilton and Dundas). Around the same time, he was appointed as the province’s Crown Attorney. In 1882, he moved to Toronto, the provincial capital, and formed a partnership with John Hoskin and several other lawyers. This enterprise grew rapidly, becoming one of the top three law firms in Canada within a decade. Frederick Harcourt’s name was added to the letterhead in 1902. Within another 10 years, the firm’s net annual income had grown to an impressive $89,000.
Almost from the start, the firm’s clients included many of the country’s largest concerns: the Canada North-West Land Company, Canadian Pacific Railway, banks and insurance companies, manufacturers and resource companies. It attracted the best and brightest: ambitious young barristers and solicitors as well as former Supreme Court judges and prime ministers. It earned a reputation as the law firm to go to for help with the most complex business law challenges, when success was essential to the organization’s future growth and prosperity.
Almost a century and a half later, in an era that's witnessed the most rapid change in history, that's one thing that hasn't changed.


1221 Avenue of the Americas26th floor
New York
New York
10020 - 1089
United States of America


Phone: 212.867.5800
Fax: 212.867.5802

News Articles [7 Associated News Articles listed on BioPortfolio]

Notogen Appoints Gary Margolis as New Chief Executive Officer

Notogen Inc. (“Notogen”), a biotechnology company developing regenerative therapeutics for conditions related to spinal degeneration, orthopedics and sports medicine, is pleas...

Small-Cap Snapshot: Crocs steps lively after posting impressive 3Q results

Small cap names on the move today are: Crocs (NASDAQ:CROX), Houghton Mifflin Harcourt (NASDAQ:HMHC), Vanda Pharmaceuticals (NASDAQ:VNDA), Pyxus International Inc (NYSE:PYX). ...

Amgen Presents Results Highlighting the Long-Term Safety and Efficacy of Repatha in the Longest Duration Study of a PCSK9 Inhibitor to Date

THOUSAND OAKS, Calif., Nov. 12, 2018 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced the final report of the Open-Label Study of Long-TERm Evaluation Against LDL-C (OSLER-1), demonstra...

[In Context] Epilepsy “detective stories” for the curious neurologist

Neurology remains as it always has been—a medical specialty whereby meticulous clinical history and examination lead to proper neuroanatomic localisation and clues as to etiologic diagnosis. The afo...

Amgen Presents Results Highlighting The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In The Longest Duration Study Of A PCSK9 Inhibitor To Date At AHA Scientific Sessions 2018

Additional Data Analyzing Treatment Patterns in the United States Shows Underutilization of LDL-C Lowering Treatments in At-Risk Patients and Need for Improved Patient Awareness of Treatment Goals T...

Amgen Announces Presentation Of Research Reinforcing The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In High-Risk Patients At AHA Scientific Sessions 2018

Additional Analyses of Real-World Data Will Explore Treatment Utilization and Understanding of Treatment Goals in Patients at High Risk for Cardiovascular Events THOUSAND OAKS, Calif., Nov. 5, 2018 ...

CORRECTING and REPLACING Alpine Investors Has Entered Into an Agreement to Acquire the Riverside Clinical and Standardized Testing Portfolio of Houghton Mifflin Harcourt (NASDAQ: HMHC) (HMH)

Seventh paragraph of release should read: The Riverside clinical and standardized testing portfolio contributed approximately $80 million in billings to HMH in 2017. (instead of T...

Drugs and Medications [0 Results]


PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

A successful treatment for hepatocellular carcinoma with Osler-Rendu-Weber disease using radiofrequency ablation under laparoscopy.

Hepatocellular carcinoma (HCC) can be difficult to diagnose and treat in patients with Osler-Rendu-Weber disease due to vascular malformation and regenerative nodular hyperplasia. In addition, percuta...

The « Osler » group : a new opportunity to think about « becoming a physician ».

Issues of professionalism and professional identity formation, particularly amongst young doctors, have been the object of increasing attention. This is explained in part by the evolution of the hospi...

HIV and tuberculosis co-infection in a highly HIV-infected population of rivers state, Nigeria.

Human Immunodeficiency Virus (HIV) and tuberculosis (TB) are considered as key players in the global health scene. This study sought to determine the prevalence of TB among HIV-positive attendees of t...

Hyaline membrane disease (HMD): an historical and Oslerian perspective.

Hyaline membrane disease (HMD) offers an illustration of a disease discovered during the lifetime of William Osler and effectively treated in the twentieth century-the perspective that suggests that t...

Dermal Clues to Systemic Diseases.

Many systemic diseases go along with dermal involvement. Only a few of systemic diseases show characteristic skin derangements directly leading to the diagnosis of the underlying disease. Ten of these...

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Pilot Study With Octreotide LAR in Patients With GI Bleeding Due to Rendu-Osler-Weber

The purpose of this study is to determine whether long-acting octreotide is safe and effective in the treatment of patients with Rendu-Osler-Weber (e.g. HHT). The study hypothesis is that...

Immunmodulation in Patients With HHT

Hereditary haemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber syndrome, is an inherited multisystemic disorder. Literature and our clinical observation suggest that HHT is ...

ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome

Scientific Objectives Primary objective : Demonstrate that oral intake of tranexamic acid significantly reduces the risk of epistaxis occurrence, estimated by the average monthly duration ...

Symptoms and Treatment Results in Hereditary Hemorrhagic Telangiectasia

Hereditary haemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber syndrome, is an inherited multisystemic disorder with recurrent epistaxis, mucocutaneous telangiectasia and vi...

Sleep Quality in (COPD) Patients (COPD: Chronic Obstructive Pulmonary Disease)

Patients with COPD, in addition to daytime symptoms, may suffer from nocturnal disturbances. The frequency of nocturnal problems has been reported to be higher in COPD than in the general ...

Companies [4 Associated Companies listed on BioPortfolio]

Osler, Hoskin & Harcourt LLP

In the fall of 1862, five years before Confederation, Britton Bath Osler began to practise law in the village of Dundas, Upper Canada (now the Province of Ontario), about 40 miles west of Toronto. He ...

Harcourt, Inc

Harcourt is a global education company serving students and teachers in PreK through grade 12, adult learners, and readers of all ages. Harcourt companies provide a variety of books, print, and electr...

Houghton Mifflin Harcourt

With education products and services used by 57 million students throughout all 50 U.S. states and 120 countries, Houghton Mifflin Harcourt is a global education and learning comp...

Houghton Mifflin Harcourt Trade Publishing

More Information about "Osler, Hoskin & Harcourt LLP" on BioPortfolio

We have published hundreds of Osler, Hoskin & Harcourt LLP news stories on BioPortfolio along with dozens of Osler, Hoskin & Harcourt LLP Clinical Trials and PubMed Articles about Osler, Hoskin & Harcourt LLP for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Osler, Hoskin & Harcourt LLP Companies in our database. You can also find out about relevant Osler, Hoskin & Harcourt LLP Drugs and Medications on this site too.

Quick Search


Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record